Investigation of genomic instability in paediatric Barrett's oesophagus using laser microdissection on paraffin-embedded endoscopic biopsies

Journal of Pediatric Gastroenterology and Nutrition

Volumn 45, Issue 1, 2007, Pages 44-49

  Cohen, Marta C ^a   Vergani, Patricia ^a   Vigovich, Felix ^a   Thomson, Mike ^a   Taylor, Chris J ^a   Hammond, David ^a  

^a SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Barrett's oesophagus; Genomic instability; Laser dissection microscope

Indexed keywords

FORMALDEHYDE; GENOMIC DNA; MOLECULAR MARKER; PARAFFIN; TOLONIUM CHLORIDE;

ADOLESCENT; ARTICLE; ASTHMA; BARRETT ESOPHAGUS; CELL SELECTION; CEREBRAL PALSY; CHILD; CLINICAL ARTICLE; COLON ADENOCARCINOMA; COMPUTER PROGRAM; CONTROLLED STUDY; DISEASE MARKER; DNA DETERMINATION; DNA EXTRACTION; DYSPHAGIA; DYSPLASIA; ENDOSCOPIC BIOPSY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGITIS; ESOPHAGUS BIOPSY; ESOPHAGUS MUCOSA; GENE AMPLIFICATION; GENETIC ANALYSIS; GENOMIC INSTABILITY; GOBLET CELL; HIATUS HERNIA; HISTOLOGY; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; LASER MICRODISSECTION; LASER MICROSCOPE; MICROSATELLITE INSTABILITY; OBESITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; SQUAMOUS EPITHELIUM; STAINING; VOMITING;

ADOLESCENT; BARRETT ESOPHAGUS; BIOPSY; CHILD; CHILD, PRESCHOOL; ESOPHAGOSCOPY; ESOPHAGUS; GENETIC MARKERS; HUMANS; MICRODISSECTION; MICROSATELLITE INSTABILITY; PARAFFIN EMBEDDING; SEQUENCE ANALYSIS, DNA;

EID: 34347344992     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/MPG.0b013e318054b0ac     Document Type: Article

References (35)

1. Rabinovitch PS, Reid BJ, Haggitt RC, et al. Progression to cancer in Barrett's esophagus is associated with genomic instability. Lab Invest 1989;60:65-71.
2. Dahms BB, Rothstein FC. Barrett's esophagus in children: a consequence of chronic gastroesophageal reflux. Gastroenterology 1984;86:318-23.
3. Dimmick JE, Jevon GP, Hassall EG. Pediatric gastritis. In: Dahms BB, Qualman SJ, eds. Gastrointestinal Diseases. Perspectives in Pediatric Pathology. Vol. 20, Basel: Karger; 1997:35-76.
4. Noffsinger A. Neoplastic risk assessment in Barrett's esophagus: how far have we come? Hum Pathol 2003;34:965-7.
5. British Society of Gastroenterology. Guidelines for the diagnosis and management of Barrett's columnar-lined oesophagus. Available at: http://www.bsg.org.uk/pdf_word_docs/Barretts_Oes.pdf. Accessed April 7, 2007.
6. Sanders DSA, Taniere P, Harrison RF, et al. Clinical and molecular pathology of the metaplasia-dysplasia-carcinoma sequence in Barrett's oesophagus. Curr Diagn Pathol 2003;9:235-41.
7. Watson A, Caygill CPJ. The frequency of development of adenocarcinoma in Barrett's oesophagus - implications for surveillance. Gastroenterology 2002;122:A350.
8. Cameron AJ, Ott BJ, Payne WS. The incidence of adenocarcinoma in columnar-lined (Barrett's) oesophagus. N Engl J Med 1985;313:857-9.
9. Spechler SJ, Robbins AH, Rubins HB, et al. Adenocarcinoma and Barrett's esophagus. An overrated risk? Gastroenterology 1984;87:927-33.
10. Dulai GS, Shekelle PG, Jensen DM, et al. Dysplasia and risk of further neoplastic progression in a regional veterans administration Barrett's cohort. Am J Gastroenterol 2005;100:775-83.
11. Younes M, Ertan A, Lechago J. P53 protein and malignant progression in Barrett's metaplasia (Barrett's esophagus). Am J Gastroenterol 2003;98:1201.
12. Hassal E. Co-morbidities in childhood Barrett's esophagus. J Pediatr Gastroenterol Nutr 1997;25:255-60.
13. Tytgat GNJ. Does endoscopic surveillance in esophageal columnar metaplasia (Barrett's esophagus) have any real value? Endoscopy 1995;27:19-25.
14. Gimenez A, Minguela A, de Haro M, et al. DNA ploidy status and proliferative activity as markers of malignant potential in Barrett's esophagus: flow cytometric studies using routinely paraffin-embedded tissue. World J Surg 2000;24:72-7.
15. Huang Y, Boynton RF, Blount PL, et al. Loss of heterozygosity involves multiple tumour suppressor genes in human esophageal cancers. Cancer Res 1992;52:6525-30.
16. Jankowski JA, Wright NA, Meltzer SJ, et al. Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus. Am J Pathol 1999;154:965-73.
17. Ferrando I, Ferrando J, Reig G, et al. Barrett's esophagus, markers to distinguish risk groups. Rev Esp Enferm Dig 1998;90:431-40.
18. Suspiro A, Dias Pereira A, Alfonso A, et al. Losses of heterozygosity on chromosomes 9p and 17p are frequent events in Barrett's metaplasia not associated with dysplasia or adenocarcinoma. Am J Gastroenterol 2003;98:728-34.
19. Sanz-Ortega J, Hernandez S, Saez MC, et al. 3p21, 5q21, 9p21 and 17p13.1 allelic deletions are potential markers of individuals with high risk of developing adenocarcinoma in Barrett's epithelium without dysplasia. Hepatogastroenterology 2003;50:404-7.
20. DeNardi FG, Riddell RH. Esophagus. In: Sternberg SS, (ed). Histology for Pathologists, 2nd ed. Philadelphia: Lippincott-Raven; 1997, chapter 19.
21. Suraweera N, Duval A, Reperant M, et al. Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR. Gastroenterology 2002;123:1804-11.
22. Gold B. Outcomes of pediatric gastroesophageal reflux disease: in the first year of life, in childhood, and in adults . . . oh, and should we really leave Helicobacter pylori alone? J Pediatr Gastroenterol Nutr 2003;37 (Suppl 1):S33-9.
23. Thomson M. Esophagitis. In: Walker WA, Goulet O, Kleinman RE, (eds) et al. Pediatric Gastrointestinal Disease: Pathophysiology, Diagnosis, Management, 4th ed. Hamilton, ON: BC Decker; 2004. pp. 400-23.
24. Deurloo JA, Ekkelkamp S, Taminiau JA, et al. Esophagitis and Barrett esophagus after correction of esophageal atresia. J Pediatr Surg 2005;8:1227-31.
25. Phillips RW, Frierson HF Jr, Moskaluk CA. Cdx2 as a marker of epithelial intestinal differentiation in the esophagus. Am J Surg Pathol 2003;27:1442-7.
26. Eda A, Osawa H, Satoh K, et al. Aberrant expression of CDX2 in Barrett's epithelium and inflammatory esophageal mucosa. J Gastroenterol 2003;38:14-22.
27. Offerhaus GJ, Correa P, van Eeden S, et al. Report of an Amsterdam working group on Barrett esophagus. Virchows Arch 2003;443:602-8.
28. Evans SC, Gillis A, Geldenhuys L, et al. Microsatellite instability in esophageal adenocarcinoma. Cancer Lett 2004;212:241-51.
29. Romagnoli S, Roncalli M, Graziani D, et al. Molecular alterations of Barrett's esophagus on microdissected endoscopic biopsies. Lab Invest 2001;81:241-7.
30. Reid BJ, Haggitt RC, Rubin CE, et al. Barrett's esophagus. Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma. Gastroenterology 1987;93:1-11.
31. Koppert LB, Wijnhoven BP, van Dekken H, et al. The molecular biology of esophageal adenocarcinoma. J Surg Oncol 2005;92:169-90.
32. Wang S, Zhan M, Yin J, et al. Transcriptional profiling suggests that Barrett's metaplasia is an early intermediate stage in esophageal carcinogenesis. Oncogene 2006;25:3346-56.
33. Caygill CP, Watson A, Lao-Sirieix P, et al. Barrett's oesophagus and adenocarcinoma. World J Surg Oncol 2004;2:12.
34. Öberg S, Wenner J, Johansson J, et al. Barrett esophagus. Risk factors for progression to dysplasia and adenocarcinoma. Ann Surg 2005;242:49-54.
35. Coad RE, Shepherd NA. Barrett's oesophagus: definition, diagnosis and pathogenesis. Curr Diag Pathol 2003;9:218-27.